During the past decade, New Hanover Regional Medical Center conducted 33 clinical trials. In the 10-year time frame, 33 clinical trials started and 17 clinical trials were completed, i.e. on average, 51.5% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 11 clinical trials were completed. i.e. 91.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "New Hanover Regional Medical Center" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 13 trials, followed by "National Cancer Institute (NCI)" with 12 trials sponsored, "Duke University" with 4 trials sponsored, "Fujirebio Diagnostics, Inc." with 4 trials sponsored and "NRG Oncology" with 4 trials sponsored. Other sponsors include 21 different institutions and companies that sponsored additional 24 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "New Hanover Regional Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 23 trials as a collaborator, "NRG Oncology" with 8 trials as a collaborator, "Cancer and Leukemia Group B" with 4 trials as a collaborator, "New Hanover Regional Medical Center" with 4 trials as a collaborator and "Eastern Cooperative Oncology Group" with 3 trials as a collaborator. Other collaborators include 29 different institutions and companies that were collaborators in the rest 31 trials.

According to Clinical.Site data, the most researched conditions in "New Hanover Regional Medical Center" are "Lung Cancer" (5 trials), "Breast Cancer" (4 trials), "Colorectal Cancer" (4 trials), "Heart Failure" (4 trials) and "Ovarian Seromucinous Carcinoma" (4 trials). Many other conditions were trialed in "New Hanover Regional Medical Center" in a lesser frequency.

Most popular intervention types in "New Hanover Regional Medical Center" are "Drug" (37 trials), "Other" (20 trials), "Procedure" (12 trials), "Device" (10 trials) and "Radiation" (9 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (9 trials), "Computed Tomography" (5 trials), "Paclitaxel" (5 trials), "Questionnaire Administration" (5 trials) and "cisplatin" (4 trials). Other intervention names were less common.

The vast majority of trials in "New Hanover Regional Medical Center" are 42 trials for "All" genders, 15 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "New Hanover Regional Medical Center". undefined are not yet recruiting, 7 are recruiting, 12 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 37 completed trials in New Hanover Regional Medical Center, 1 suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in New Hanover Regional Medical Center, 1 "Phase 1" clinical trials were conducted, 17 "Phase 2" clinical trials and 25 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 11 trials that are defined as “Not Applicable".

New Hanover Regional Medical Center has several departments that took part in Clinical trials: "New Hanover Regional Medical Center/Zimmer Cancer Center" - 55 trials, "NHRMC Radiation Oncology - Supply" - 23 trials, "Coastal Carolina Radiation Oncology" - 12 trials, "NHRMC Radiation Oncology - 16th Street" - 11 trials, "Novant Health Cancer Institute Radiation Oncology - Wilmington" - 8 trials, "Cape Fear Cancer Specialists-Leland" - 3 trials, "Cape Fear Cancer Specialists" - 3 trials, "Cape Fear Heart Associates" - 3 trials